期刊文献+

免疫抑制剂在炎症性肠病治疗中的应用 被引量:16

Application of immunosuppressants in the treatment of inflammatory bowel disease
下载PDF
导出
摘要 炎症性肠病具有慢性发展、反复发作的特点,可导致肠道黏膜损伤、功能异常以及出血和穿孔等并发症,治疗目标是达到和维持疾病的"深度"缓解,从而改善疾病的长期自然病程。本文主要介绍目前在炎症性肠病治疗中免疫抑制剂的适当选用及其副作用,为临床合理、安全地选用免疫抑制剂治疗炎症性肠病提供参考。 Patients with inflammatory bowel disease(IBD) are characterized by the persistence and recurrence of the disease which can cause some complications such as intestinal mucosal damage,dysfunction and bleeding and perforation.The therapeutic goal is to achieve and maintain a "deep" remission of the disease and to improve the long-term nature course of disease outcomes.This paper focuses on an introduction of an appropriate choice of immunosuppressants and their adverse reactions in the treatment of IBD so as to provide references for a reasonable,safe choice of immunosuppressants in clinic.
作者 戎兰
出处 《上海医药》 CAS 2016年第1期11-15,共5页 Shanghai Medical & Pharmaceutical Journal
关键词 免疫抑制剂 炎症性肠病 克罗恩病 溃疡性结肠炎 immunosuppressants inflammatory bowel disease Crohn's disease ulcerative colitis
  • 相关文献

参考文献3

二级参考文献20

  • 1王烜 ,欧阳钦 .沙利度胺对炎症性肠病疗效的实验研究[J].四川大学学报(医学版),2005,36(4):548-551. 被引量:6
  • 2Frφslie KF,Jahnsen J,Moum BA,et al.Mucosal healing in inflammatory bowel disease:results from a Norwegian population-based cohort.Gastroenterology,2007,133:412-422.
  • 3Schnitzler F,Fidder H,Ferrante M,et al.Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn's disease.Inflamm Bowel Dis,2009,15:1295-1301.
  • 4D'Haens GR,Fedorak R,Lémann M,et al.Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohn's disease.Inflamm Bowel Dis,2009,15:1599-1604.
  • 5Colombel JF,Sandborn WJ,Reinisch W,et al.Infliximab,azathioprine,or combination therapy for Crohn's disease.N Engl J Med,2010,362:1383-1395.
  • 6Hindorf U,Lindqvist M,Hildebrand H,et al.Adverse events leading to modification of therapy in a large cohort of patients with inflammatory bowel disease.Aliment Pharmacol Ther,2006,24:331-342.
  • 7Gisbert JP,Gomollón F.Thiopurine-induced myelotoxicity in patients with inflammatory bowel disease:a review.Am J Gastroenterol,2008,103:1783-1800.
  • 8Connell WR,Kamm MA,Ritchie JK,et al.Bone marrow toxicity caused by azathioprine in inflammatory bowel disease:27 years of experience.Gut,1993,34:1081-1085.
  • 9Prefontaine E,Sutherland LR,Macdonald JK,et al.Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease.Cochrane Database Syst Rev,2009,(1):CD000067.
  • 10Zheng JJ,Chu XQ,Shi XH,et al.Efficacy and safety of azathioprine maintenance therapy in a group of Crohn's disease patients in China.J Dig Dis,2008,9:84-88.

共引文献29

同被引文献184

引证文献16

二级引证文献101

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部